Skip to main content
OpenTrials
Completed

NCT Number: NCT07347899

Speech-based AI-driven Diagnostics and Rehabilitation for Oral and Oropharyngeal Cancer.

Participants diagnosed with oral cancer, oropharyngeal cancer, or oral potentially malignant lesions, as well as healthy controls, had their speech audio recordings collected for the development and validation of AI-driven models for diagnosis and prognosis prediction of oral cancer and oropharyngeal cancer.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of oral and maxillofacial surgery, Hospital of Stomatology, Sun Yat-sen University

Guangzhou, Guangdong, 510055, China

About this study

Participants were instructed to articulate three sustained vowels (/a/, /i/, /u/) repeatedly at a moderate volume and pace, with three repetitions per vowel and each utterance lasting at least one second. We developed a neuromorphic computing framework that orthogonally decomposes acoustic features into ultra-dimensional omics representations, enabling the characterization of both localized lesions and systemic physiological conditions. The study collected a comprehensive spectrum of biological profiles, including sociodemographic characteristics, tumor metrics, oral function-related factors, patient-reported outcome measures (PROMs), immunoinflammatory indices, and general health status indicators, to thoroughly investigate the paralinguistic representations of transformed speech omics features. These features were then rigorously evaluated for their clinical efficacy across multiple diagnostic tasks, including screening, early detection, pathological diagnosis, disease staging, and risk factor identification.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosed as having OC or OPC regardless of concrete pathological subtype (e.g., epithelial, adenoid, odontogenic)
  • without a history of other tumor-related treatment before the initial evaluation, such as radiotherapy and chemotherapy
  • native Chinese speakers

Exclusion criteria

  • hearing impairment
  • history of stuttering, cerebrovascular accident, brain trauma, neurodegenerative diseases
  • severe dental or maxillofacial deformity
  • cleft lip, cleft palate, and related post-treatment status
  • severe cardiology conditions, breathing/pulmonology disorders, psychiatric disorders or other illnesses preventing patients from receiving standard surgery

Treatment and study plan

Primary outcomes

  1. AUC value

    Time frame: From enrollment to the report of surgical pathology,up to two weeks.

    Area under the receiver operating characteristic curve (AUC) for discriminating OC/OPC from healthy controls

Sponsors and collaborators

Lead sponsor

Yudong Xiao

Other

Registry information

Official study title

A Preliminary Study on the Phonetics of Resonance and Articulation Disorders Caused by Defects of the Oral and Maxillofacial Speech Organs and Speech Therapy

Acronym: speech omics

Important dates

Study start
2017
Primary completion
2022
Study completion
2022
First posted
Jan 16, 2026
Registry last updated
Jan 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.